top of page

Ever Expanding Intellectual Property Portfolio

Rectangle 11663.png
gray background.png

U.S. Provisional Applications Filed to Date

U.S. Provisional Patent Applications

U.S. PCT (Non- Provisional)  Patent Applications

29

19

10

Blanketing the Biosynthetic Production Space

gray background 2.png

U.S. Provisional Patent Application

63/424,567

“ Alternative Enzyme Sources”

gray background 2.png

U.S. Provisional Patent Application

63/424,563

“ In Vivo Production of 5-Methoxy-N,N-Dimethyltryptanime in Escherichia Coli”

gray background 2.png

U.S. Provisional Patent Application

63/424,527

“Optimizing the De Novo Production of Psilocybin in E. Coli ”

gray background 2.png

U.S. Provisional Patent Application

63/392,527

“NMDA Receptor Antagonists Containing Compositions and Method of Treatment”

gray background 2.png

U.S. Provisional Patent Application

63/144,044

“Psychopharmacological Interactions Between Tryptamines Present in Psilocybe Mushrooms”

gray background.png

U.S.PCT (Non- Provisional)  Patent Application

PCT/US2020/51543

“Methods for the Production of Psilocybin and Intermediates Thereof”

U.S. Provisional Patent Application 62/926,875 “Methods for the Production of Psilocybin”

U.S.PCT (Non- Provisional)  Patent Application 62/990,633 “Methods for the Production of Psilocybin and Intermediates or Side Products

gray background.png

U.S.PCT (Non- Provisional)  Patent Application

PCT /US2022/070094

“Psilocybin and Norbaeocystin Compositions and Methods of Treatment”

U.S. Provisional Patent Application 63/135,054 “Psychopharmacological Interactions Between Tryptamines Present in Psilocybe Mushrooms”

U.S. Provisional Patent Application 63/219,430 “Psilocybin and Norbaeocystin Compositions and Treatment Methods ”

gray background.png

U.S.PCT (Non- Provisional)  Patent Application

PCT/US2022/070132

“ System/Methods for Pharmaceutical Prod. of Psilocybin and Intermediates or Side Products”

U.S. Provisional Patent Application 63/135,864 “System/Methods for Pharmaceutical Production of Psilocybin & Intermediates”

gray background.png

U.S.PCT (Non- Provisional)  Patent Application

PCT/US2022/071797

“Optimized Methods for the Production of Psilocybin & Intermediates or Side Products”

U.S. Provisional Patent Application 63/176,590 “Optimized Methods for the Production of Psilocybin & Intermediates ”

 U.S. Provisional Patent Application 63/263,611 “Optimized Methods for the Production of Psilocybin & Intermediates ”

gray background.png

U.S.PCT (Non- Provisional)  Patent Application

PCT/US2022/074579

“Methods for the Production of Methylated Tryptamine derivatives/Intermediates or Side Products”

U.S. Provisional Patent Application 63/203,970“Methods of Production Methylated Tryptami/Intermediates/Side Products ”

gray background.png

U.S.PCT (Non- Provisional)  Patent Application

PCT/US2022/079308

“Methods for Improved Prod. of Psilocybin/ Intermediates/ Side Products Enzyme optimization”

U.S. Provisional Patent Application 63/263,607 “Improved Pro. of Psilocybin/Intermediates/Side Products Enzyme optimization”

gray background.png

U.S.PCT (Non- Provisional)  Patent Application

PCT/US2022/079308

“Metabolic Engineering Methods for the Production of Psilocybin and Intermediates or Side Products”

U.S. Provisional Patent Application 63/263,614 “ Methods of Prod. Methylated Tryptamines,/Intermediates / Sides Products ”

gray background.png

U.S.PCT (Non- Provisional)  Patent Application

PCT/US2022/079321

“Methods for Prod. of Non-Natural  Tryptophans,  Tryptamines, Psilocybin Interm. / Derivatives”

U.S. Provisional Patent Application 63/263,616 “Prod. Non-Natural Tryptophans/Tryptamines/Psilocybin Inter.Derivatives”

U.S. Provisional Patent Application 63/263,623 “Methods for De Novo Prod. of Psilocybin/Intermediates/Side products”

gray background.png

U.S.PCT (Non- Provisional)  Patent Application

PCT/US2022/079329

“Alternative Biosynthesis Pathways for the Production of Psilocybin and Intermediates or Side products”

U.S. Provisional Patent Application 63/203,970 “Alternative Biosynthesis Pathways for Psilocybin/Intermediates/Side products”

bottom of page